JP TSE －

千寿製薬株式会社

Revenue

¥45.7B

≈ $289.9M

Net income

−¥4.7B

≈ −$29.5M

Total assets

¥101B

≈ $638.0M

Equity ratio

80.2%

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥45.7B	−¥4.7B	¥101B	¥80.8B	80.2%	EDINET (consol.)
Mar 2025	¥48.9B	¥2.4B	¥100B	¥83.8B	83.6%	EDINET (consol.)
Mar 2024	¥49.0B	¥7.5B	¥98.5B	¥81.8B	83.1%	EDINET (consol.)
Mar 2023	¥46.4B	¥6.7B	¥88.2B	¥73.8B	83.6%	EDINET (consol.)
Mar 2022	¥40.9B	¥7.9B	¥83.9B	¥67.6B	80.5%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.